Literature DB >> 136773

Treatment of bone marrow aplasia by mismatched bone marrow transplantation after conditioning with antilymphocyte globulin--long-term results.

G Mathé, L Schwarzenberg.   

Abstract

Twenty patients with very severe bone marrow aplasia were treated with mismatched bone marrow transplants. Engraftment and transitory chimerism (from 2-10 months) not complicated by secondary disease occurred in 4 patients. Of these, 3 are still alive after 5 years, with a compensated hematologic status. Engraftment failed in 16 patients; only 1 of these is still alive after 5 years.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 136773

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

Review 1.  Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success.

Authors:  Elaine M Sloand; A J Barrett
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

2.  Aplastic anemia: immunosuppressive therapy in 2010.

Authors:  Antonio M Risitano; Fabiana Perna
Journal:  Pediatr Rep       Date:  2011-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.